Lv1
10 积分 2022-04-09 加入
Ovarian cancer-derived IL-4 promotes immunotherapy resistance
2天前
已完结
Bacterial infection in endometriosis: a silver-lining for the development of new non-hormonal therapy?
4个月前
已完结
A Novel SIK2 Inhibitor SIC-19 exhibits Synthetic Lethality with PARP inhibitors in Ovarian Cancer
5个月前
已完结
Patient-derived organoids in ovarian cancer: Current research and its clinical relevance
5个月前
已完结
Pregnancy with an intrauterine device in place
1年前
已完结
Cancer antigen 125 (CA 125) and carcinoembryonic antigen (CEA) ratio can identify different stages of ovarian cancer preoperatively
2年前
已完结
Avelumab alone or in combination with chemotherapy versus chemotherapy alone in platinum-resistant or platinum-refractory ovarian cancer (JAVELIN Ovarian 200): an open-label, three-arm, randomised, phase 3 study
2年前
已完结
皖公网安备34019202002308
